Capstone Asset Management’s Select Medical SEM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
$586K Sell
70,844
-2,876
-4% -$21.6K 0.02% 819
2017
Q1
$530K Sell
73,720
-6,830
-8% -$49.5K 0.01% 877
2016
Q4
$575K Sell
80,550
-5,142
-6% -$35.8K 0.02% 842
2016
Q3
$623K Sell
85,692
-371
-0.4% -$2.36K 0.02% 819
2016
Q2
$504K Buy
86,063
+316
+0.4% +$2.09K 0.02% 918
2016
Q1
$546K Buy
85,747
+6,106
+8% +$32.8K 0.02% 873
2015
Q4
$511K Buy
79,641
+25,316
+47% +$158K 0.01% 907
2015
Q3
$316K Buy
54,325
+2,079
+4% +$15.4K 0.01% 1199
2015
Q2
$456K Sell
52,246
-18,004
-26% -$151K 0.01% 1022
2015
Q1
$561K Buy
+70,250
New +$525K 0.02% 999

Other funds holding SEM

Capstone Asset Management's SEM Position: Q2 2017 in Review

Capstone Asset Management reduced its Select Medical (SEM) stake by 3.9% in Q2 2017, selling an estimated $21.6K and leaving 70,844 shares worth $586K. The position accounts for 0.02% of the portfolio, ranked #819.

Capstone Asset Management first reported a position in SEM in Q1 2015 and has held it in 10 quarters since. The position peaked at $623K in Q3 2016. 155 funds tracked by Wall St. Rank hold SEM as of Q2 2017.

  • Capstone Asset Management held 70,844 shares of Select Medical worth $586K as of Q2 2017.
  • Capstone Asset Management sold 2,876 Select Medical shares in Q2 2017, an estimated $21.6K.
  • Select Medical made up 0.02% of Capstone Asset Management's portfolio in Q2 2017, its #819 holding.
  • Capstone Asset Management first reported a position in Select Medical in Q1 2015 and has held it in 10 quarters since.
  • Capstone Asset Management's Select Medical position peaked at $623K in Q3 2016.
  • 155 funds tracked by Wall St. Rank held Select Medical as of Q2 2017.

Based on Capstone Asset Management's 13F filing for Q2 2017, filed 10 Jul 2017.